Breast Cancer

Get Email Updates

Related Checklists

Breast Cancer Bloggers

Breast Cancer Guide

Maryann Gromisch RN Guide

Have a question? We're here to help. Ask the Community.

ASK

Free Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER!

Dormant Breast Cancer

By Linda Fugate PhD HERWriter November 8, 2011 - 6:51am
 
Rate This
1 comments View Comments
Breast Cancer related image Photo: Getty Images

Breast cancer can relapse more than 25 years after diagnosis. During the time between initial treatment and relapse, cancer cells are considered to be in a state of dormancy. Lisa Willis of University College London, UK, and colleagues performed a mathematical analysis of what happens during the dormancy period.

Circulating tumor cells have been detected in breast cancer patients 8 to 22 years after surgical treatment. These cells remained at a steady concentration over a study period of two years. Willis found that primary tumors seed at most six micrometastases before mastectomy surgery, and in most cases only one remains in long-term dormancy.

Three mechanisms have been proposed for dormant cancer:

1. Solitary dormant cells
2. Micrometastases restricted in size by their lack of blood vessels
3. Micrometastases with blood vessels that are held to a steady size by the immune system

“Breast cancer is infamous for long gaps between primary treatment and recurrence,” Willis noted. Current treatments are only marginally effective against dormant cancers that relapse after five years.

Jonathan W. Uhr of the University of Texas Southwestern Medical Center, Dallas, Texas, and Klaus Pantel of the University Medical Center Hamburg-Eppendorf, Germany provided more insights into dormant cancer. These authors reported that 20 percent of breast cancer patients who are clinically disease-free will experience cancer relapse 7 to 25 years after mastectomy.

Similar dormant patterns are found in thyroid, renal, and prostate cancers, as well as B-cell lymphoma and melanoma. Lung and colon cancer rarely relapse after a long period of dormancy.

Uhr and Pantel reported that the innate immune response does not appear to have a major role in preventing cancer growth. Studies of organ transplant patients on immunosuppressive drugs show little or no increase in the incidence of common types of cancer, including breast, prostate, and lung cancer.

However, the adaptive immune response may be a different story.

 
Rate This
1 comments View Comments

We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.

Add a Comment1 Comments

Image
Anonymous

Thought this was a great article. Being a breast cancer (recurring trip. neg. ductal carcinoma) patient, I know well the feeling of helplessness having gone just three years before suddenly finding myself with another tumor,only four months after a clean mammogram. You never really do feel safe and secure again.

November 8, 2011 - 6:26pm
Image CAPTCHA
By hitting submit, you agree to EmpowHER's terms of service and privacy policy

Improved

616 Health

Changed

293 Lives

Saved

210 Lives
3 lives impacted in the last 24 hrs Learn More

Health Theater Videos

View More Videos

Take our Featured Poll

Have you ever had breast cancer? :
View Results